Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection

(1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical medicine Vol. 10; no. 2; p. 265
Main Authors Favresse, Julien, Gillot, Constant, Oliveira, Maxime, Cadrobbi, Julie, Elsen, Marc, Eucher, Christine, Laffineur, Kim, Rosseels, Catherine, Van Eeckhoudt, Sandrine, Nicolas, Jean-Baptiste, Morimont, Laure, Dogné, Jean-Michel, Douxfils, Jonathan
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 13.01.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3–98.1%) to 96.6% (95% CI: 88.1–99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4–85.1%) to 88.8% (95% CI: 79.7–94.7%) while the specificity ranged from 96.3% (95% CI: 90.8–99.0%) to 99.1% (95% CI: 95.0–100%). The VITROS automated assay showed a 100% (95% CI: 95.5–100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6–100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients.
AbstractList (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3–98.1%) to 96.6% (95% CI: 88.1–99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4–85.1%) to 88.8% (95% CI: 79.7–94.7%) while the specificity ranged from 96.3% (95% CI: 90.8–99.0%) to 99.1% (95% CI: 95.0–100%). The VITROS automated assay showed a 100% (95% CI: 95.5–100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6–100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients.
(1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3-98.1%) to 96.6% (95% CI: 88.1-99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4-85.1%) to 88.8% (95% CI: 79.7-94.7%) while the specificity ranged from 96.3% (95% CI: 90.8-99.0%) to 99.1% (95% CI: 95.0-100%). The VITROS automated assay showed a 100% (95% CI: 95.5-100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6-100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients.(1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard gold method for the diagnosis of SARS-CoV-2 infection. Antigen detection (AD) tests are more rapid, less laborious, and less expensive alternatives but still require clinical validation. (2) Methods: This study compared the clinical performance of five AD tests, including four rapid AD (RAD) tests (biotical, Panbio, Healgen, and Roche) and one automated AD test (VITROS). For that purpose, 118 (62.8%) symptomatic patients and 70 (37.2%) asymptomatic subjects were tested, and results were compared to RT-PCR. (3) Results: The performance of the RAD tests was modest and allowed us to identify RT-PCR positive patients with higher viral loads. For Ct values ≤25, the sensitivity ranged from 93.1% (95% CI: 83.3-98.1%) to 96.6% (95% CI: 88.1-99.6%), meaning that some samples with high viral loads were missed. Considering the Ct value proposed by the CDC for contagiousness (i.e., Ct values ≤33) sensitivities ranged from 76.2% (95% CI: 65.4-85.1%) to 88.8% (95% CI: 79.7-94.7%) while the specificity ranged from 96.3% (95% CI: 90.8-99.0%) to 99.1% (95% CI: 95.0-100%). The VITROS automated assay showed a 100% (95% CI: 95.5-100%) sensitivity for Ct values ≤33, and had a specificity of 100% (95% CI: 96.6-100%); (4) Conclusions: Compared to RAD tests, the VITROS assay fully aligned with RT-PCR for Ct values up to 33, which might allow a faster, easier and cheaper identification of SARS-CoV-2 contagious patients.
Author Van Eeckhoudt, Sandrine
Oliveira, Maxime
Cadrobbi, Julie
Douxfils, Jonathan
Laffineur, Kim
Morimont, Laure
Dogné, Jean-Michel
Elsen, Marc
Favresse, Julien
Nicolas, Jean-Baptiste
Gillot, Constant
Eucher, Christine
Rosseels, Catherine
AuthorAffiliation 1 Department of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; julie.cadrobbi@slbo.be (J.C.); marc.elsen@slbo.be (M.E.); christine.eucher@slbo.be (C.E.); kim.laffineur@slbo.be (K.L.); catherine.rosseels@slbo.be (C.R.)
2 Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium; constant.gillot@unamur.be (C.G.); maxime.oliveira@qualiblood.eu (M.O.); laure.morimont@unamur.be (L.M.); jean-michel.dogne@unamur.be (J.-M.D.); jonathan.douxfils@unamur.be (J.D.)
3 Department of Internal Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; sandrine.vaneeckhoudt@slbo.be (S.V.E.); jeanbaptiste.nicolas@slbo.be (J.-B.N.)
4 Qualiblood S.A., 5000 Namur, Belgium
AuthorAffiliation_xml – name: 1 Department of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; julie.cadrobbi@slbo.be (J.C.); marc.elsen@slbo.be (M.E.); christine.eucher@slbo.be (C.E.); kim.laffineur@slbo.be (K.L.); catherine.rosseels@slbo.be (C.R.)
– name: 3 Department of Internal Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium; sandrine.vaneeckhoudt@slbo.be (S.V.E.); jeanbaptiste.nicolas@slbo.be (J.-B.N.)
– name: 2 Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium; constant.gillot@unamur.be (C.G.); maxime.oliveira@qualiblood.eu (M.O.); laure.morimont@unamur.be (L.M.); jean-michel.dogne@unamur.be (J.-M.D.); jonathan.douxfils@unamur.be (J.D.)
– name: 4 Qualiblood S.A., 5000 Namur, Belgium
Author_xml – sequence: 1
  givenname: Julien
  surname: Favresse
  fullname: Favresse, Julien
– sequence: 2
  givenname: Constant
  orcidid: 0000-0002-4151-9760
  surname: Gillot
  fullname: Gillot, Constant
– sequence: 3
  givenname: Maxime
  surname: Oliveira
  fullname: Oliveira, Maxime
– sequence: 4
  givenname: Julie
  surname: Cadrobbi
  fullname: Cadrobbi, Julie
– sequence: 5
  givenname: Marc
  surname: Elsen
  fullname: Elsen, Marc
– sequence: 6
  givenname: Christine
  surname: Eucher
  fullname: Eucher, Christine
– sequence: 7
  givenname: Kim
  surname: Laffineur
  fullname: Laffineur, Kim
– sequence: 8
  givenname: Catherine
  surname: Rosseels
  fullname: Rosseels, Catherine
– sequence: 9
  givenname: Sandrine
  surname: Van Eeckhoudt
  fullname: Van Eeckhoudt, Sandrine
– sequence: 10
  givenname: Jean-Baptiste
  surname: Nicolas
  fullname: Nicolas, Jean-Baptiste
– sequence: 11
  givenname: Laure
  surname: Morimont
  fullname: Morimont, Laure
– sequence: 12
  givenname: Jean-Michel
  surname: Dogné
  fullname: Dogné, Jean-Michel
– sequence: 13
  givenname: Jonathan
  orcidid: 0000-0002-7644-5298
  surname: Douxfils
  fullname: Douxfils, Jonathan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33450853$$D View this record in MEDLINE/PubMed
BookMark eNptkUFr3DAQhUVJaNI0p96LoJdCcCpLsixfCssmbQKBQpL2KsayvNFiS64kF_rvK7Np2IRIhxnQp8e8ee_QgfPOIPShJOeMNeTLVo8lIZRQUb1Bx5TUdUGYZAd7_RE6jXFL8pGS07J-i44Y4xWRFTtG05WBrki-WCpe-3GCYKN32Pf4FibbYXAdXs3Jj5BM7lyyG-PwhUlGJ5vBexNTxL0POD0YfGFh43y0cRG4W93eFWv_q6D42vU7_j067GGI5vSxnqCf3y7v11fFzY_v1-vVTaF5XaVCtLXoQJPO0LZtZFsBMGGkpgyykOkkF02ZLwiiedMySngjJGE9iK42AtgJ-rrTneZ2NJ02LgUY1BTsCOGv8mDV8xdnH9TG_1G1pJLxOgt8fhQI_vecTarRRm2GAZzxc1SU17KSgogF_fQC3fo5uGxPUcFLwvPaSaY-7k_0NMr_MDJwtgN08DEG0z8hJVFL2mov7UyXL2htEywrznbs8Oqff9X7q-8
CitedBy_id crossref_primary_10_5937_jomb0_36107
crossref_primary_10_1002_14651858_CD013705_pub3
crossref_primary_10_1007_s00430_023_00774_9
crossref_primary_10_1128_spectrum_02351_21
crossref_primary_10_1038_s41598_023_31177_8
crossref_primary_10_1016_j_jcv_2021_104938
crossref_primary_10_1007_s11845_021_02863_1
crossref_primary_10_3390_bioengineering10030322
crossref_primary_10_1016_j_jviromet_2021_114299
crossref_primary_10_1002_jmv_26884
crossref_primary_10_1007_s15010_021_01723_5
crossref_primary_10_1016_j_cca_2023_117586
crossref_primary_10_1002_jmv_27094
crossref_primary_10_3390_v13081459
crossref_primary_10_3389_fmed_2022_870738
crossref_primary_10_3390_diagnostics11071290
crossref_primary_10_3390_jcm10173854
crossref_primary_10_3390_diagnostics12020475
crossref_primary_10_3390_v14081653
crossref_primary_10_1016_j_diagmicrobio_2021_115490
crossref_primary_10_1016_j_heliyon_2023_e23518
crossref_primary_10_1016_j_jcv_2021_104909
crossref_primary_10_1016_j_jcvp_2021_100020
crossref_primary_10_1128_Spectrum_00846_21
crossref_primary_10_3390_jcm10112404
crossref_primary_10_1371_journal_pmed_1003735
crossref_primary_10_1016_j_ijid_2021_03_051
crossref_primary_10_1016_j_talanta_2023_124462
crossref_primary_10_1136_bmjebm_2021_111828
crossref_primary_10_1080_23744235_2022_2083226
crossref_primary_10_1515_cclm_2022_0849
crossref_primary_10_1007_s00430_021_00719_0
crossref_primary_10_3390_diagnostics12020447
crossref_primary_10_1371_journal_pone_0266375
crossref_primary_10_1186_s12985_024_02371_5
crossref_primary_10_1016_j_jcv_2023_105419
crossref_primary_10_1515_dx_2022_0067
crossref_primary_10_1002_jmv_27108
crossref_primary_10_3233_HAB_211513
crossref_primary_10_3390_v14040654
crossref_primary_10_1515_cclm_2022_1166
crossref_primary_10_31362_patd_1160801
crossref_primary_10_3390_diagnostics11122217
crossref_primary_10_3390_diagnostics12061302
crossref_primary_10_1016_j_jcv_2021_104994
crossref_primary_10_3390_diagnostics12061388
crossref_primary_10_1002_jmv_27153
crossref_primary_10_1371_journal_pmed_1004011
crossref_primary_10_1038_s41598_021_02197_z
crossref_primary_10_1515_cclm_2022_1039
crossref_primary_10_1016_j_eclinm_2021_100954
crossref_primary_10_1016_j_diagmicrobio_2021_115514
crossref_primary_10_1515_cclm_2022_0661
crossref_primary_10_1002_jmv_27679
crossref_primary_10_3390_diagnostics12010110
crossref_primary_10_1515_cclm_2022_0345
crossref_primary_10_3389_fmicb_2021_714242
crossref_primary_10_3390_biomedicines10092327
crossref_primary_10_1093_labmed_lmac089
crossref_primary_10_3390_v13050809
crossref_primary_10_1371_journal_pone_0269329
crossref_primary_10_3233_HAB_200441
crossref_primary_10_3390_diagnostics11112110
crossref_primary_10_3390_jcm10132774
crossref_primary_10_1515_cclm_2021_0455
Cites_doi 10.1016/j.cmi.2020.09.030
10.1007/s10096-020-03913-9
10.1016/j.jcv.2020.104712
10.1016/j.jcv.2020.104612
10.1016/j.jviromet.2020.114024
10.5858/arpa.2020-0443-SA
10.1016/j.ijid.2020.08.029
10.1016/j.jcv.2020.104500
10.1016/j.jcv.2020.104654
10.1016/j.jcv.2020.104455
10.1515/cclm-2020-1413
10.2807/1560-7917.ES.2020.25.32.2001483
10.3390/diagnostics10040202
10.3390/v12121420
10.1515/cclm-2020-1602
10.1016/j.jcv.2020.104684
10.1093/clinchem/hvaa213
10.1515/dx-2020-0154
10.1128/JCM.02589-20
10.1016/j.cmi.2020.09.057
10.1002/14651858.CD013705
10.1101/2020.08.04.20167932
10.1101/2020.10.16.20213850
10.1016/j.bios.2020.112817
10.1007/s15010-020-01542-0
10.1016/j.jcv.2020.104659
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/jcm10020265
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-0383
ExternalDocumentID PMC7828347
33450853
10_3390_jcm10020265
Genre Journal Article
GeographicLocations Belgium
United States--US
Switzerland
GeographicLocations_xml – name: Switzerland
– name: United States--US
– name: Belgium
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
HMCUK
HYE
IAO
IHR
ITC
KQ8
M48
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
GROUPED_DOAJ
NPM
3V.
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c475t-6b76dac0de2bb98b5aa36e8c23afeced84691919a60c49b320496803fa6d7e6a3
IEDL.DBID 7X7
ISSN 2077-0383
IngestDate Thu Aug 21 14:29:30 EDT 2025
Fri Jul 11 05:11:39 EDT 2025
Sun Jun 29 12:34:51 EDT 2025
Thu Jan 02 22:32:37 EST 2025
Tue Jul 01 04:34:24 EDT 2025
Thu Apr 24 23:09:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords COVID-19
SARS-CoV-2
antigen testing
automated assay
manual assay
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-6b76dac0de2bb98b5aa36e8c23afeced84691919a60c49b320496803fa6d7e6a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7644-5298
0000-0002-4151-9760
OpenAccessLink https://www.proquest.com/docview/2641044210?pq-origsite=%requestingapplication%
PMID 33450853
PQID 2641044210
PQPubID 5046890
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7828347
proquest_miscellaneous_2478586067
proquest_journals_2641044210
pubmed_primary_33450853
crossref_primary_10_3390_jcm10020265
crossref_citationtrail_10_3390_jcm10020265
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210113
PublicationDateYYYYMMDD 2021-01-13
PublicationDate_xml – month: 1
  year: 2021
  text: 20210113
  day: 13
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Journal of clinical medicine
PublicationTitleAlternate J Clin Med
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Andreani (ref_27) 2020; 39
Singanayagam (ref_28) 2020; 25
ref_12
Kruttgen (ref_13) 2020; 288
ref_11
ref_10
ref_31
Liu (ref_16) 2020; 173
ref_18
Linares (ref_14) 2020; 133
ref_15
Mak (ref_17) 2020; 133
Mak (ref_22) 2021; 134
Bohn (ref_5) 2020; 58
ref_25
ref_24
ref_23
ref_20
ref_1
ref_3
Scohy (ref_19) 2020; 129
ref_2
Ogawa (ref_30) 2020; 131
Hirotsu (ref_29) 2020; 99
Mak (ref_21) 2020; 129
ref_26
ref_8
ref_4
ref_7
ref_6
Cerutti (ref_9) 2020; 132
33939481 - Ann Intern Med. 2021 May;174(5):JC56
References_xml – ident: ref_7
– ident: ref_15
  doi: 10.1016/j.cmi.2020.09.030
– volume: 39
  start-page: 1059
  year: 2020
  ident: ref_27
  article-title: Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
  publication-title: Eur. J. Clin. Microbiol. Infect. Dis.
  doi: 10.1007/s10096-020-03913-9
– ident: ref_24
– volume: 134
  start-page: 104712
  year: 2021
  ident: ref_22
  article-title: Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104712
– volume: 131
  start-page: 104612
  year: 2020
  ident: ref_30
  article-title: Another false-positive problem for a SARS-CoV-2 antigen test in Japan
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104612
– volume: 288
  start-page: 114024
  year: 2020
  ident: ref_13
  article-title: Comparison of the SARS-CoV-2 Rapid Antigen Test to the Real Star Sars-CoV-2 RT PCR Kit
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2020.114024
– ident: ref_31
  doi: 10.5858/arpa.2020-0443-SA
– volume: 99
  start-page: 397
  year: 2020
  ident: ref_29
  article-title: Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2020.08.029
– volume: 129
  start-page: 104500
  year: 2020
  ident: ref_21
  article-title: Evaluation of rapid antigen test for detection of SARS-CoV-2 virus
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104500
– volume: 132
  start-page: 104654
  year: 2020
  ident: ref_9
  article-title: Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104654
– volume: 129
  start-page: 104455
  year: 2020
  ident: ref_19
  article-title: Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104455
– volume: 58
  start-page: 2001
  year: 2020
  ident: ref_5
  article-title: IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2020-1413
– volume: 25
  start-page: 2001483
  year: 2020
  ident: ref_28
  article-title: Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2020.25.32.2001483
– ident: ref_1
  doi: 10.3390/diagnostics10040202
– ident: ref_20
  doi: 10.3390/v12121420
– ident: ref_6
– ident: ref_25
– ident: ref_2
  doi: 10.1515/cclm-2020-1602
– ident: ref_4
– volume: 133
  start-page: 104684
  year: 2020
  ident: ref_17
  article-title: Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104684
– ident: ref_18
  doi: 10.1093/clinchem/hvaa213
– ident: ref_23
  doi: 10.1515/dx-2020-0154
– ident: ref_12
  doi: 10.1128/JCM.02589-20
– ident: ref_10
  doi: 10.1016/j.cmi.2020.09.057
– ident: ref_11
  doi: 10.1002/14651858.CD013705
– ident: ref_26
  doi: 10.1101/2020.08.04.20167932
– ident: ref_8
  doi: 10.1101/2020.10.16.20213850
– volume: 173
  start-page: 112817
  year: 2020
  ident: ref_16
  article-title: Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2020.112817
– ident: ref_3
  doi: 10.1007/s15010-020-01542-0
– volume: 133
  start-page: 104659
  year: 2020
  ident: ref_14
  article-title: Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104659
– reference: 33939481 - Ann Intern Med. 2021 May;174(5):JC56
SSID ssj0000884217
Score 2.43974
Snippet (1) Background: The detection of SARS-CoV-2 RNA in nasopharyngeal samples through real-time reverse transcription-polymerase chain reaction (RT-PCR) is...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 265
SubjectTerms Antigens
Asymptomatic
Automation
Clinical medicine
Coronaviruses
COVID-19
Laboratories
Patients
Reading
Severe acute respiratory syndrome coronavirus 2
Software
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RT9swED4xkKa9TBtsIxsgT-IJyVsaO7bzgFBVhrpJ3QPQibfIjh1RxJyOptL27zknaUQZ4imRfEms--z4--TzHcDhoIiZ1KWjqdWKov5KqNHcUSm4STQvjWjSF09-ivGU_7hKrzZgVYyzc-DiSWkX6klN726__P3z7wQn_HFQnCjZv94Uv0MiUVQT6QvYwiVJhhk66Xh-80tWiiP3bs_nPX5mfUX6j2Y-jpZ8sPycvYHXHW8kwxbot7Dh_Da8nHQ74zswHyNYtK5ouJJRX12QVCU51_OZJdpbMlzWFVJUh3e-Dnk4yamrm2AsTy6xOwuCHJYgJySnbQjebBFecDE8v6Cj6hdNyPcueMu_g-nZt8vRmHbVFGjBZVpTYaSwuoitS4zJlEm1ZsKpImEIVeEsEpEMxVumRVzwzLAEtYNQMSu1sNIJzd7Dpq-82wWCEiV2IWuMVWk4Fa1dZjJEnA9Ky7TTERytPJoXXarxUPHiNkfJEdyfP3B_BIe98bzNsPG02d4Kmnw1SnJkcygnEdo4gs99M06QsOuhvauWaMOlShXqNBnBhxbJ_juMcSSoKYtArmHcG4Tk2-stfnbdJOFGZqUYlx-f79YneJWEIJh4QAdsDzbru6XbRxZTm4NmhN4DC5ryEw
  priority: 102
  providerName: Scholars Portal
Title Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/33450853
https://www.proquest.com/docview/2641044210
https://www.proquest.com/docview/2478586067
https://pubmed.ncbi.nlm.nih.gov/PMC7828347
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTUK8IO6EXWSkPSFZS2PHdp6m0m0qSJ1Qt6G-RXbsiCJwCk3_P8eJm62AeEoiO4nl48v32cffATgZVSmTunY0t1pR5F8ZNZo7KgU3mea1EZ188exKTG_5p0W-iAtu6-hWuR0Tu4HaNlVYIz_FiRuZA0eGcrb6SUPUqLC7GkNoPIT9IF0WXLrkQg5rLNiD8AXZH8tjyO5Pv1U_guYoEo98dyL6C13-6SR5b9a5fApPIlwk496-z-CB88_h0SxuiL-A1RRtRNuGhiuZDEEFSVOTuV4tLdHekvGmbRCZOrzzbZDfJOeu7XywPLnB4qwJQleCUJCc9553y3X4wPV4fk0nzReakY_RZ8u_hNvLi5vJlMYgCrTiMm-pMFJYXaXWZcYUyuRaM-FUlTG0UOUs4o8COVuhRVrxwrAMKYNQKau1sNIJzV7Bnm-8ewMEmUnqgliMVXk4DK1dYQo0NB_VlmmnE3i_rdGyigrjIdDF9xKZRqj-8l71J3AyZF71whr_zna4NU0Ze9e6vGsLCbwbkrFfhM0O7V2zwTxcqlwhPZMJvO4tOfyHMY64NGcJyB0bDxmC5vZuil9-7bS3EVApxuXb_xfrAB5nwfclHdERO4S99tfGHSF4ac1x10KPYf_DxdXnOT7NuPoNtHnyUw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kG2Ck8YJkLY0dO3lAqLSbWrZWqOvQ3jI7dkQRS8qaCvFP8Tdybj5YAfG2p0TKyTnZZ9_vZ5_vAPa7qc-kyiwNjYoo8q-AasUtlYLrQPFMi3X64vFEDM_4h_PwfAt-NndhXFhlsyauF2pTpG6P_AAdNzIHjgzl3eIbdVWj3OlqU0KjMotj--M7Urbl29EAx_d1EBwdzvpDWlcVoCmXYUmFlsKo1Dc20DqOdKgUEzZKA4Yqp9agQ46RxMRK-CmPNQsQQ4vIZ5kSRlqhGLZ7C7Y5QyrTge33h5OP03ZXB-csqiiri4CMxf7Bl_TSZTlFqhNuur6_8OyfYZnX_NzRfbhXA1TSqyzqAWzZ_CHcHtdH8I9gMUSroGVB3ZP02zKGpMjIVC3mhqjckN6qLBALW3zLS5fwkwxsuY76yskM1VkSBMsEwScZVLF-86Vr4LQ3PaX94hMNyKiOEssfw9mNdPAT6ORFbp8BQS7kW5eexkShu36tbKxjNC3ezQxTVnnwpunRJK1zmrvSGl8T5Dau-5Nr3e_Bfiu8qFJ5_FtsrxmapJ7Py-S39Xnwqv2MM9Edr6jcFiuU4TIKIySE0oOn1Ui2_2GMIxIOmQdyY4xbAZfle_NLPv-8zvaNEC5iXO78X62XcGc4G58kJ6PJ8S7cDVzkjd-lXbYHnfJqZZ8jdCr1i9peCVzc9BT5BZNWLyc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEO-mFDBSuSBZTWLHTg4VWu2y2qW0Qn2gvQU7dsQimmy7WVX8NX4d47zoAuLWUyJl5Fj2jP2NPfMNwF6Q-Uyq3NLIqJii_xVSrbilUnAdKp5rUdMXHx2LyTn_MItmG_Czy4VxYZXdmlgv1KbM3Bn5Pm7c6Dlwl3GSt2ERn0bjd4tL6ipIuZvWrpxGoyKH9sc1um_Lg-kI5_pNGI7fnw0ntK0wQDMuo4oKLYVRmW9sqHUS60gpJmychQy7n1mDm3OCDk2ihJ_xRLMQ8bSIfZYrYaQVimG7d-CuZFHgbEzOZH--g9aLnZVNSiBjib__LbtwfKfo9ETrm-BfyPbPAM0bO974AdxvoSoZNLr1EDZs8Qi2jtrL-MewmKB-0Kqk7kmGfUFDUubkRC3mhqjCkMGqKhEVW3wrKkf9SUa2quO_CnKG3VkShM0EYSgZNVF_86Vr4HRwckqH5WcakmkbL1Y8gfNbGd6nsFmUhd0Ggl6Rbx1RjYkjl4itbKITVDIe5IYpqzx4241omrXs5q7IxvcUvRw3_OmN4fdgrxdeNKQe_xbb7aYmbS17mf7WQw9e95_RJt1FiypsuUIZLuMoRtdQevCsmcn-P4xxxMQR80CuzXEv4Pi-178U86817zeCuZhxufP_br2CLTSM9OP0-PA53AtdCI4f0IDtwmZ1tbIvEENV-mWtrAS-3LZ1_AI6kTH3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Head-to-Head+Comparison+of+Rapid+and+Automated+Antigen+Detection+Tests+for+the+Diagnosis+of+SARS-CoV-2+Infection&rft.jtitle=Journal+of+clinical+medicine&rft.au=Favresse%2C+Julien&rft.au=Gillot%2C+Constant&rft.au=Oliveira%2C+Maxime&rft.au=Cadrobbi%2C+Julie&rft.date=2021-01-13&rft.pub=MDPI+AG&rft.eissn=2077-0383&rft.volume=10&rft.issue=2&rft.spage=265&rft_id=info:doi/10.3390%2Fjcm10020265&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon